UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 355

Sortiert nach

Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape

Journal of neuro-oncology, 2017-09, Vol.134 (3), p.495-504

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

Journal of neuro-oncology, 2018-12, Vol.140 (3), p.485-496

2018

Link zum Volltext

Verfügbarkeit prüfen

The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma

Journal of neuro-oncology, 2019-01, Vol.141 (2), p.347-354

2019

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas

Journal of neuro-oncology, 2015-04, Vol.122 (2), p.313-320

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis

Journal of neuro-oncology, 2017-01, Vol.131 (1), p.125-133

2017

Link zum Volltext

Verfügbarkeit prüfen

The role of imaging in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

Journal of neuro-oncology, 2014-07, Vol.118 (3), p.435-460

2014

Link zum Volltext

Verfügbarkeit prüfen

The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

Journal of neuro-oncology, 2017-07, Vol.133 (3), p.641-651

2017

Link zum Volltext

Verfügbarkeit prüfen

Meningioma recurrence rates following treatment: a systematic analysis

Journal of neuro-oncology, 2018, Vol.136 (2), p.351-361

2018

Link zum Volltext

Verfügbarkeit prüfen

Trametinib for progressive pediatric low-grade gliomas

Journal of neuro-oncology, 2018-11, Vol.140 (2), p.435-444

2018

Link zum Volltext

Verfügbarkeit prüfen

Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma

Journal of neuro-oncology, 2017-01, Vol.131 (2), p.255-265

2017

Link zum Volltext

Verfügbarkeit prüfen

Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma

Journal of neuro-oncology, 2018-11, Vol.140 (2), p.403-412

2018

Link zum Volltext

Verfügbarkeit prüfen

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Journal of neuro-oncology, 2019-10, Vol.145 (1), p.177-184

2019

Link zum Volltext

Verfügbarkeit prüfen

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

Journal of neuro-oncology, 2013-04, Vol.112 (2), p.141-152

2013

Link zum Volltext

Verfügbarkeit prüfen

Estimating progression-free survival in patients with glioblastoma using routinely collected data

Journal of neuro-oncology, 2017-12, Vol.135 (3), p.621-627

2017

Link zum Volltext

Verfügbarkeit prüfen

Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma

Journal of neuro-oncology, 2015-10, Vol.125 (1), p.183-190

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases

Journal of neuro-oncology, 2016-05, Vol.128 (1), p.93-100

2016

Link zum Volltext

Verfügbarkeit prüfen

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

Journal of neuro-oncology, 2007-11, Vol.85 (2), p.133-148

2007

Link zum Volltext

Verfügbarkeit prüfen

Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis

Journal of neuro-oncology, 2023-12, Vol.165 (3), p.439-447

2023

Link zum Volltext

Verfügbarkeit prüfen

The role of cytoreductive surgery in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

Journal of neuro-oncology, 2014-07, Vol.118 (3), p.479-488

2014

Link zum Volltext

Verfügbarkeit prüfen

The role of adjuvant radiotherapy in atypical meningioma

Journal of neuro-oncology, 2013-11, Vol.115 (2), p.241-247

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience

Journal of neuro-oncology, 2016-01, Vol.126 (1), p.193-200

2016

Link zum Volltext

Verfügbarkeit prüfen

WHO grade II and III meningiomas: a study of prognostic factors

Journal of neuro-oncology, 2009-12, Vol.95 (3), p.367-375

2009

Link zum Volltext

Verfügbarkeit prüfen

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases

Journal of neuro-oncology, 2021-03, Vol.152 (1), p.125-134

2021

Link zum Volltext

Verfügbarkeit prüfen

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas

Journal of neuro-oncology, 2019-09, Vol.144 (3), p.519-528

2019

Link zum Volltext

Verfügbarkeit prüfen

Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?

Journal of neuro-oncology, 2015-05, Vol.123 (1), p.141-150

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 355

Suche als RSS-Feed

Aktive Filter

SpracheRumänisch

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Zeitschrift / SerieJournal Of Neuro-Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(355)
Mit Volltextzugriff
(355)

Publikationsform

Artikel
(355)

Sprache

Englisch
(355)
Japanisch
(57)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

J Neurooncol
(1)

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape

Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review

The consistency of neuropathological diagnoses in patients undergoing surgery for suspected recurrence of glioblastoma

Phase II study of mTORC1 inhibition by everolimus in neurofibromatosis type 2 patients with growing vestibular schwannomas

Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis

The role of imaging in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?

Meningioma recurrence rates following treatment: a systematic analysis

Trametinib for progressive pediatric low-grade gliomas

Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide resistance in glioma

Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma

Diagnostics and treatment of diffuse intrinsic pontine glioma: where do we stand?

Discriminating radiation necrosis from tumor progression in gliomas: a systematic review what is the best imaging modality?

Estimating progression-free survival in patients with glioblastoma using routinely collected data

Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma

Tumor DNA in cerebral spinal fluid reflects clinical course in a patient with melanoma leptomeningeal brain metastases

Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

Clinical course of ventriculoperitoneal shunting for hydrocephalus following glioblastoma surgery: a systematic review and meta-analysis

The role of cytoreductive surgery in the management of progressive glioblastoma: A systematic review and evidence-based clinical practice guideline

The role of adjuvant radiotherapy in atypical meningioma

Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience

WHO grade II and III meningiomas: a study of prognostic factors

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases

Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas

Characterization of pseudoprogression in patients with glioblastoma: is histology the gold standard?

Aktive Filter

Suchergebnisse filtern